The coal industry once provided more than half of U.S. electricity production. But it has been in steep decline for decades ...

As Donald Trump hits his 100th day in office Tuesday, his imprint is everywhere. But the long-term impact is often unclear.

Rep. Alexandria Ocasio-Cortez, D-N.Y., ran against Connolly for the job but was defeated as the majority of Democrats opted ...

There's new uncertainty about updated COVID-19 shots this fall after the Trump administration's handling of a shot from ...

The Trump administration on Monday announced federal officials are launching investigations into Harvard University and the ...

At the insistence of Justice Neil Gorsuch, she withdrew the allegation that the other side had lied but held firm to the ...

Federal regulators have requested that Novavax conduct an additional randomized clinical trial of its COVID-19 vaccine, a costly demand that could threaten the company’s ability to comply, The Wall ...

Novavax, the little-known Maryland company that received a $1.6 billion deal from the federal government for its experimental coronavirus vaccine, announced encouraging results in two preliminary ...

Shares of Novavax (NVAX) are under pressure on Thursday following Robert F. Kennedy Jr.’s comments on the company’s COVID shot approval delay. The Secretary of Health and Human Services ...

"If they don't approve Novavax, they put every COVID vaccine at risk," Jefferies analyst Roger Song said, adding that the Novavax vaccine works "as good as, if not better than other COVID vaccines".

(Reuters) -Vaccine maker Novavax's shares plunged nearly 20% at market close on Thursday, after Health and Human Services Secretary Robert F. Kennedy Jr. raised concerns about the company's COVID-19 ...